O2B Kids Apopka Opens Today

O2B Kids Apopka Opens Today GlobeNewswire January 09, 2026 APOPKA, Fla., Jan. 09, 2026 (GLOBE NEWSWIRE) — O2B Early Education, a trusted leader in early childhood education, is proud to announce the opening of its 83rd location, O2B Kids Apopka, continuing its mission to inspire young learners and support families through high-quality, engaging early education. […]

Calumet to Attend UBS Global Energy & Utilities Winter Conference

Calumet, Inc. (NASDAQ: CLMT) (“Calumet”) announced today that it plans to attend the UBS Global Energy & Utilities Winter Conference on Tuesday, January 13th and will hold one-on-one investor meetings throughout the day. About Calumet Calumet, Inc. (NASDAQ: CLMT) manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers

Pomerantz LLP Shares Class Action Details With Investors in StubHub Holdings, Inc. – STUB

NEW YORK CITY, NY / ACCESS Newswire / January 9, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against StubHub Holdings, Inc. ("StubHub" or the "Company") (NYSE:STUB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Class Action Initiated by Pomerantz LLP Against Skye Bioscience, Inc. – SKYE

NEW YORK CITY, NY / ACCESS Newswire / January 9, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Skye Bioscience, Inc. ("Skye" or the "Company") (NASDAQ:SKYE) and certain officers.�� The class action, filed in the United States District Court for the Southern District of California, and docketed under 25-cv-03177,

Pomerantz LLP Advises Investors of Class Action Involving Varonis Systems, Inc. – VRNS

NEW YORK CITY, NY / ACCESS Newswire / January 9, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ:VRNS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

PRMB, PRMW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Primo Brands Corporation to Contact the Firm Today!

NEW YORK CITY, NY / ACCESS Newswire / January 9, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Primo Brands Corporation ("Primo" or "the Company") (NYSE:PRMB; PRMW) and certain of its officers. Class Definition This lawsuit seeks to recover damages

Pomerantz LLP Advises Investors of Class Action Against F5, Inc. – FFIV

NEW YORK CITY, NY / ACCESS Newswire / January 9, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against F5, Inc. ("F5" or the "Company") (NASDAQ:FFIV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Pomerantz LLP Advises Investors of Class Action Against Ardent Health, Inc. – ARDT

NEW YORK CITY, NY / ACCESS Newswire / January 9, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE:ARDT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Honda Announces New Lines of Models that Represent "Honda Sports DNA" at Tokyo Auto Salon 2026

Honda Motor Co., Ltd. today unveiled new concept models and race machines that embody "Honda passion for driving performance," at the Tokyo Auto Salon 2026 which started today at Makuhari Messe in Chiba Prefecture, Japan. Honda introduced two new product lines – "Sport Line" for on-road models and "Trail Line" for off-road models – that

Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation

(NASDAQ:PASW), HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) — Ping An Biomedical Co., Ltd. (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) today announced that it has entered into a series of share purchase agreements with several investors. Ping An Biomedical Co., Ltd. has entered into a series of share purchase agreements from several

Scroll to Top